Skip to content

A single center randomized controlled study on the treatment of mixed hemorrhoids with double layered serrated ligation

A single center randomized controlled study on the treatment of mixed hemorrhoids with double layered serrated ligation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108417
Enrollment
Unknown
Registered
2025-08-29
Start date
2023-12-08
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mixed hemorrhoid

Interventions

group a:Accept double layered serrated ligation treatment
group b:Accept external stripping and internal ligation treatment
group c:Accept external peeling and internal ligation combined with skin bridge plastic surgery treatment

Sponsors

Jiangxi University of Traditional Chinese Medicine Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Refer to the diagnostic and grading criteria for mixed hemorrhoids in the 2020 edition of the Chinese Hemorrhoid Disease Treatment Guidelines; Complies with circular mixed hemorrhoids, with morphological changes of internal and external hemorrhoids penetrating up and down, surrounding the anus in a petal like shape, and no normal skin between hemorrhoids. Internal hemorrhoids are stage III-IV patients;   2. Age between 18 and 80 years old, gender not limited; 3. Has not received surgical treatment for hemorrhoids; 4. Agree to the surgery and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Combined with other anorectal diseases, including anal fissure, anal fistula, perianal abscess, rectal prolapse, infectious diseases, etc; 2. Accompanied by malignant tumors, cardiovascular and cerebrovascular diseases, hematological diseases, infectious diseases, liver cirrhosis, portal hypertension, psychiatric patients, etc; 3. Pregnant and lactating women; 4. Individuals with allergic constitution or allergies to anesthetics or drugs used during the perioperative period in this treatment plan; 5. Patients currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Swelling of the wound after surgery;Clinical efficacy evaluation;

Secondary

MeasureTime frame
Surgical duration and hospital stay;Postoperative wound healing time;Smooth defecation after surgery;Degree of postoperative anal prolapse and swelling;Urinary retention within 48 hours after operation;Pain status of patients on the 1st, 3rd, 7th, and 14th day after surgery;

Countries

China

Contacts

Public ContactChen Guanghua

Jiangxi University of Traditional Chinese Medicine Affiliated Hospital

469805830@qq.com+86 136 9708 9406

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026